Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000920231 | SCV001065591 | benign | Carnitine palmitoyltransferase II deficiency | 2024-12-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005029533 | SCV005649134 | uncertain significance | Carnitine palmitoyl transferase II deficiency, severe infantile form; Carnitine palmitoyl transferase II deficiency, myopathic form; Carnitine palmitoyl transferase II deficiency, neonatal form; Encephalopathy, acute, infection-induced, susceptibility to, 4 | 2024-06-05 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000920231 | SCV001454129 | uncertain significance | Carnitine palmitoyltransferase II deficiency | 2020-01-17 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003960384 | SCV004783519 | likely benign | CPT2-related disorder | 2022-11-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |